Wang H, Paulson KR, Pease SA, Watson S, Comfort H, Zheng P, et al. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21. Lancet. 2022;399(10334):1513–36.

Article  CAS  Google Scholar 

Mohapatra RK, Pintilie L, Kandi V, Sarangi AK, Das D, Sahu R, et al. The recent challenges of highly contagious COVID-19, causing respiratory infections: symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy. Chem Biol Drug Des. 2020;96(5):1187–208.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sah P, Fitzpatrick MC, Zimmer CF, Abdollahi E, Juden-Kelly L, Moghadas SM, Singer BH, Galvani AP. Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis. Proc Natl Acad Sci. 2021;118(34):e2109229118. https://doi.org/10.1073/pnas.2109229118.

Buitrago-Garcia D, Egli-Gany D, Counotte MJ, Hossmann S, Imeri H, Ipekci AM, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. PLoS Med. 2020;17(9):e1003346.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kronbichler A, Kresse D, Yoon S, Lee KH, Effenberger M, Shin JI. Asymptomatic patients as a source of COVID-19 infections: a systematic review and meta-analysis. Int J Infect Dis. 2020;98:180–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsitsilonis OE, Paraskevis D, Lianidou E, Terpos E, Akalestos A, Pierros V, Kostaki EG, Kastritis E, Moutsatsou P, Politou M, Scorilas A, Sphicopoulos T, Thomaidis N, Trougakos IP, Tsakris A, Voulgaris N, Daskalaki CC, Evangelakou Z, Fouki C, Gianniou DD, … Sfikakis PP. SARS-CoV-2 Infection is asymptomatic in nearly half of adults with robust anti-spike protein receptor-binding domain antibody response. Vaccines. 2021;9(3):207. https://doi.org/10.3390/vaccines9030207

Wang B, Andraweera P, Elliott S, Mohammed H, Lassi Z, Twigger A, et al. Asymptomatic SARS-CoV-2 infection by age: a global systematic review and meta-analysis. Pediatr Infect Dis J. 2023;42(3):232–9.

Article  PubMed  Google Scholar 

Earle KA, Ambrosino DM, Fiore-Gartland A, Goldblatt D, Gilbert PB, Siber GR, et al. Evidence for antibody as a protective correlate for COVID-19 vaccines. Vaccine. 2021;39(32):4423–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021;27(7):1205–11.

Article  CAS  PubMed  Google Scholar 

Muecksch F, Wise H, Templeton K, Batchelor B, Squires M, McCance K, et al. Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: a serological analysis. The Lancet Microbe. 2022;3(7):e493–502.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moss P. The T cell immune response against SARS-CoV-2. Nat Immunol. 2022;23(2):186–93.

Article  CAS  PubMed  Google Scholar 

Scurr MJ, Lippiatt G, Capitani L, Bentley K, Lauder SN, Smart K, et al. Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunity. Nat Commun. 2022;13(1):5422.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jarjour NN, Masopust D, Jameson SC. T cell memory: understanding COVID-19. Immunity. 2021;54(1):14–8.

Article  CAS  PubMed  Google Scholar 

Le Bert N, Clapham HE, Tan AT, Chia WN, Tham CYL, Lim JM, Kunasegaran K, Tan LWL, Dutertre CA, Shankar N, Lim JME, Sun LJ, Zahari M, Tun ZM, Kumar V, Lim BL, Lim SH, Chia A, Tan YJ, Tambyah PA, … Tam CC. Highly unctional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection. J Exp Med. 2021;218(5):e20202617. https://doi.org/10.1084/jem.20202617.

Chan YH, Fong SW, Poh CM, Carissimo G, Yeo NK, Amrun SN, et al. Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2. EMBO Mol Med. 2021;13(6):e14045.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie C, Li Q, Li L, Peng X, Ling Z, Xiao B, et al. Association of early inflammation with age and asymptomatic disease in COVID-19. J Inflamm Res. 2021;14:1207–16.

Article  PubMed  PubMed Central  Google Scholar 

Ferreira I, Lee CYC, Foster WS, Abdullahi A, Dratva LM, Tuong ZK, et al. Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly. Cell Rep. 2023;42(8):112991.

Article  CAS  PubMed  Google Scholar 

van der Maaten L, Hinton G. Viualizing data using t-SNE. J Mach Learn Res. 2008;9:2579–605.

Google Scholar 

Van Gassen S, Callebaut B, Van Helden MJ, Lambrecht BN, Demeester P, Dhaene T, et al. FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data. Cytometry A. 2015;87(7):636–45.

Article  PubMed  Google Scholar 

Sekine T, Perez-Potti A, Rivera-Ballesteros O, Strålin K, Gorin JB, Olsson A, et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell. 2020;183(1):158–68.e14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stephenson E, Reynolds G, Botting RA, Calero-Nieto FJ, Morgan MD, Tuong ZK, et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat Med. 2021;27(5):904–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soares-Schanoski A, Sauerwald N, Goforth CW, Periasamy S, Weir DL, Lizewski S, et al. Asymptomatic SARS-CoV-2 infection is associated with higher levels of serum IL-17C, matrix metalloproteinase 10 and fibroblast growth factors than mild symptomatic COVID-19. Front Immunol. 2022;13:821730.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Su F, Patel GB, Hu S, Chen W. Induction of mucosal immunity through systemic immunization: phantom or reality? Hum Vaccin Immunother. 2016;12(4):1070–9.

Article  PubMed  PubMed Central  Google Scholar 

Wei J, Pouwels KB, Stoesser N, Matthews PC, Diamond I, Studley R, et al. Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines. Nat Med. 2022;28(5):1072–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andeweg SP, de Gier B, Eggink D, van den Ende C, van Maarseveen N, Ali L, et al. Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections. Nat Commun. 2022;13(1):4738.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sterlin D, Mathian A, Miyara M, Mohr A, Anna F, Claër L, Quentric P, Fadlallah J, Devilliers H, Ghillani P, Gunn C, Hockett R, Mudumba S, Guihot A, Luyt CE, Mayaux J, Beurton A, Fourati S, Bruel T, Schwartz O, … Gorochov G. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Sci Transl Med. 2021;13(577):eabd2223. https://doi.org/10.1126/scitranslmed.abd2223.

Sheikh-Mohamed S, Isho B, Chao GYC, Zuo M, Cohen C, Lustig Y, et al. Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection. Mucosal Immunol. 2022;15(5):799–808.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hicks J, Klumpp-Thomas C, Kalish H, Shunmugavel A, Mehalko J, Denson JP, et al. Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal betacoronaviruses. J Clin Immunol. 2021;41(5):906–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nguyen TTN, Choo EM, Nakamura Y, Suzuki R, Shiina T, Shin-I T, et al. Pre-existing cross-reactive neutralizing activity against SARS-CoV-2 and seasonal coronaviruses prior to the COVID-19 pandemic (2014-2019) with limited immunity against recent emerging SARS-CoV-2 variants, Vietnam. Int J Infect Dis. 2024;139:109–17.

Article  CAS  PubMed  Google Scholar 

Song G, He W-T, Callaghan S, Anzanello F, Huang D, Ricketts J, et al. Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection. Nat Commun. 2021;12(1):2938.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jeewandara C, Jayathilaka D, Gomes L, Wijewickrama A, Narangoda E, Idampitiya D, et al. SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness. Sci Rep. 2021;11(1):2062.

Article  CAS